Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC

By GlobeNewswire,  April 16, 2019, 08:00:00 AM EDT

NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company, announced today that they will present and host 1x1 and small group meetings at the Jefferies 2019 Global Healthcare Conference taking place June 4-7 at the Grand Hyatt in New York City. Chairman, Founder, and CEO Raj Mehra, PhD and Dr. Tim Whitaker, Seelos' Head of Research and Development, will present and host the meetings.

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano

Head of Corporate Communications

Seelos Therapeutics, Inc.

(646) 293 2136





Source: Seelos Therapeutics, Inc.

This article appears in: News Headlines

Referenced Stocks: SEEL

Today's Market Activity

NASDAQ 8120.82
105.55  ▲  1.32%
DJIA 26656.39
145.34  ▲  0.55%
S&P 500 2933.68
25.71  ▲  0.88%
Data as of Apr 23, 2019